All DR-TB patients diagnose by Xpert MTB/RIF, LPA, and solid culture-based DST were included into the study while patients diagnosed on the clinical base were excluded. To evaluate the effect of diagnostics tests on the final treatment outcome based on their sputum smear result we had excluded those patients on treatment and transfer out (Fig 2).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.